華髮股份(600325.SH):擬對十字門城建進行現金增資並簽訂增資協議
格隆匯 9 月 4日丨華髮股份(600325.SH)公佈,公司全資子公司珠海華億投資有限公司(“珠海華億”)擬對控股子公司珠海十字門城建有限公司(“十字門城建”)進行現金增資並簽訂《增資協議》。
增資完成後,十字門城建註冊資本由2000萬元增加至4000萬元,公司對十字門城建持股比例變更為75%。此次增資價款約人民幣70.71億元。
十字門城建持有珠海市海潤房地產開發有限公司(“海潤公司”)55%股權,珠海城市建設集團有限公司(“珠海城建”)持有海潤公司45%股權。海潤公司主要負責開發建設“華髮城建國際海岸花園”項目(“華髮城建四季半島項目”)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.